Solu-medrol and Petit mal epilepsy - a phase IV clinical study of FDA data

Summary:

Petit mal epilepsy is reported as a side effect among people who take Solu-medrol (methylprednisolone sodium succinate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Polaramine, and have Breast cancer.

The phase IV clinical study analyzes which people have Petit mal epilepsy when taking Solu-medrol. It is created by eHealthMe based on reports of 39,265 people who have side effects when taking Solu-medrol from the FDA, and is updated regularly.

What is Solu-medrol?

Solu-medrol has active ingredients of methylprednisolone sodium succinate. It is often used in multiple sclerosis. eHealthMe is studying from 39,410 Solu-medrol users. Check the latest studies of Solu-medrol.

What is Petit mal epilepsy?

Petit mal epilepsy (absence seizure) is found to be associated with 345 drugs and 612 conditions by eHealthMe. Check the latest studies of Petit mal epilepsy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

39,265 people reported to have side effects when taking Solu-medrol.
Among them, 15 people (0.04%) have Petit mal epilepsy.

Could Solu-medrol cause Petit mal epilepsy?

Among these 15 people:

How long have people been on Solu-medrol when they have Petit mal epilepsy? *

What is the gender of people who have Petit mal epilepsy when taking Solu-medrol? *

female: 86.67 %
male: 13.33 %

What is the age of people who have Petit mal epilepsy when taking Solu-medrol? *

What are other drugs people take besides Solu-medrol? *

Vectibix: 5 people, 33.33%
Tranxene: 5 people, 33.33%
Emend: 5 people, 33.33%
Polaramine: 5 people, 33.33%
Cyclophosphamide: 2 people, 13.33%
Tysabri: 2 people, 13.33%
Tylenol: 2 people, 13.33%
Epirubicin Hydrochloride: 2 people, 13.33%
Ondansetron: 2 people, 13.33%
Xolair: 1 person, 6.67%

What are other side effects people have besides Petit mal epilepsy? *

Headache (pain in head): 6 people, 40.00%
Confusional State: 4 people, 26.67%
Visual Impairment: 2 people, 13.33%
Stress And Anxiety: 2 people, 13.33%
Dizziness: 2 people, 13.33%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 13.33%
Pain: 2 people, 13.33%
Injury: 2 people, 13.33%
Abdominal Pain Upper: 2 people, 13.33%
Swelling: 1 person, 6.67%

What are the existing conditions these people have? *

Breast Cancer: 4 people, 26.67%
Rasmussen Encephalitis (a rare inflammatory neurological disease, characterized by frequent and severe seizures, loss of motor skills and speech): 1 person, 6.67%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 1 person, 6.67%
Gout (uric acid crystals building up in the body): 1 person, 6.67%
Cardiac Disorder: 1 person, 6.67%
Birth Control: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Solu-medrol and have Petit mal epilepsy?

- Check whether Petit mal epilepsy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Solu-medrol:

Solu-medrol (39,410 reports)

Petit mal epilepsy treatments and more:

Petit mal epilepsy (7,767 reports)

How severe was Petit mal epilepsy and when was it recovered:

Petit mal epilepsy in Solu-medrol

Expand to all the drugs that have ingredients of methylprednisolone sodium succinate:

Petit mal epilepsy and drugs with ingredients of methylprednisolone sodium succinate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Solu-medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Petit mal epilepsy:

Petit mal epilepsy (345 drugs)

Browse all the conditions that are associated with Petit mal epilepsy:

Petit mal epilepsy (612 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone sodium succinate (the active ingredients of Solu-medrol) and Solu-medrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.